ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹115 Cr | ₹99 Cr | ₹100 Cr | ₹88 Cr | ₹86 Cr |
What is the latest Sundry Debtors ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹99 Cr |
| Mar2023 | ₹100 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹86 Cr |
How is Sundry Debtors of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹115 Cr | 17.08 | |
| Mar2024 | ₹99 Cr | -1.77 | |
| Mar2023 | ₹100 Cr | 13.76 | |
| Mar2022 | ₹88 Cr | 2.24 | |
| Mar2021 | ₹86 Cr | - | |
Compare Sundry Debtors of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,816.3 Cr | 9.9% | 9.5% | -32.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,477.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,934.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,469.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,250.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,038.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 9.9% |
9.5% |
-32.9% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses